Ibogaine's Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course

Business and Industry

Psychedelic Alpha

2023-06-15

Ibogaine’s Surge in Popularity Could Be a Huge Loss for the Gabonese People Unless We Shift Course

Tricia Eastman and Dr. Joseph Barsuglia advocate for a nuanced appreciation of stewardship when it comes to the use and drug development of ibogaine. Stewardship, as they explain in this Opinions‚Ä¶

Check it out!

Related News

Live and Awake in LA

Having attended the surprisingly few SoCal events over the past few years, it was such a welcome pleasure to see familiar faces coming together in LA for 3 days of meaningful conversations centered around healing, community, access, learning, and networking at Psychedelic Awakening 2025 hosted by Psychedelic Institute of Los Angeles.

Psychedelic Science 2025: Set and (Re)Setting

For its fifth installment, Psychedelic Science 2025 returned to Denver, offering three days of big ideas, heartfelt community, and some noticeable shifts in the psychedelic space. After the usual chaos of delayed flights and travel drama on Tuesday, we shared a collective sigh of relief as we finally arrived at the Colorado Convention Center, a mile high and ready to dive in.

Colorado’s Approach to Psychedelic-Assisted Therapy: An Evolution in Mental Health Care

Elizabeth Nielson, co-founder of Fluence, offers thoughts on the roll out of the 2025 psychedelic therapy program in Colorado and the opportunities it offers for mental health professionals.

Mindstate Uses AI to Design “Next-Gen” Psychedelics Combined With 5-MeO-MiPT

Mindstate Design Labs has received approval for a Phase 1 clinical trial to investigate the use of its formulation of 5-MeO-MiPT which it hopes to combine with other drugs to target precise serotonin receptors and create future psychotropic therapies.

The Psychedelic Underground’s Future Is in Consumer Packaged Goods

Let‚Äôs not kid ourselves: medical access is merely a stepping stone to legality.